Filtered library · Theme
mrd-liquid-biopsy theme · 2 dossiers
Dossiers in the mrd-liquid-biopsy theme cluster — 2 names moving on shared catalysts.
All dossiersVCYT
Veracyte, Inc.
Profitable precision-oncology dx compounder with a fresh third leg: the TrueMRD whole-genome MRD test won Medicare coverage (2026-05-15, launched 06-01), stacking on a Q1 beat-and-raise and ASCO OPTIMA/ENZAMET data. But all three binaries…
Cyclical recovery biotech-precision-therapeutics precision-oncology-diagnostics
read · →
PSNL
Personalis, Inc.
MRD/liquid-biopsy narrative still ACCELERATING on 4 Medicare wins + best-in-class ASCO data, but the catalysts already fired and price just FAILED a breakout 2026-06-05 printed a fresh 52w high $12.53, then reversed to close $10.75 (-11%).…
Earnings inflection mrd-liquid-biopsy precision-oncology-diagnostics
read · →